Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
NRx Pharmaceuticals, Inc. (NRXP) had Pre-Tax Income of $-16.53M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.10M |
|
$-16.52M |
|
$0.68M |
|
$0.43M |
|
$7.61M |
|
$-6.50M |
|
$-10.02M |
|
|
Pre-Tax Income |
$-16.53M |
$-16.52M |
|
$-16.53M |
|
$-16.53M |
|
$-16.53M |
|
$-16.52M |
|
$-6.50M |
|
$-6.33M |
|
37.65M |
|
37.65M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$29.16M |
|
$0.92M |
|
$5.00M |
|
$34.16M |
|
$33.87M |
|
-- |
|
$0.46M |
|
$34.33M |
|
$-0.17M |
|
$-2.79M |
|
$-0.17M |
|
43.16M |
|
| Cash Flow Statement Financials | |
$-13.17M |
|
$-0.90M |
|
$32.96M |
|
$7.80M |
|
$26.69M |
|
$18.89M |
|
$0.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
-- |
|
-2.42 |
|
38.69% |
|
-590.83% |
|
-590.83% |
|
-- |
|
-1501.00% |
|
-1500.45% |
|
$-14.07M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
5.34 |
|
16.84 |
|
9720.41% |
|
591.27% |
|
-48.38% |
|
9721.18% |
|
$-0.00 |
|
$-0.37 |
|
$-0.35 |
|